Experts from NYU Langone’s Cardiac and Vascular Institute discuss the latest findings in cardiovascular research and heart health at the 2015 American College of Cardiology Scientific Session.

Preventive cardiologist Dr. Howard Weintraub discusses a new class of drugs developed rapidly over the past decade that more effectively lower LDL, or “bad” cholesterol, with fewer side effects than many other medications. He explains that the takeaway, though, is still that cardiovascular disease is ultimately preventable.

“One of the unique things that we have at NYU Langone Medical Center is our Center for the Prevention of Cardiovascular Disease,” Dr. Weintraub says. “We offer an approach to the treatment of cardiovascular disease, particular prevention—primary and secondary prevention—which is really unequaled anywhere else."

Learn more about Dr. Weintraub: http://www.nyulangone.org/doctors/1457347767/howard-weintraub

Learn more about the Cardiac and Vascular Institute: http://www.nyulangone.org/locations/cardiac-vascular-institute